diazooxonorleucine and Rhabdoid Tumor

diazooxonorleucine has been researched along with Rhabdoid Tumor in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, SJ; Alt, J; Eberhart, CG; Hanaford, AR; Kaur, H; Orr, BA; Poore, B; Price, A; Raabe, EH; Rubens, JA; Slusher, BS; Wang, SZ1

Other Studies

1 other study(ies) available for diazooxonorleucine and Rhabdoid Tumor

ArticleYear
Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 10-01, Volume: 25, Issue:19

    Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Proliferation; Diazooxonorleucine; Female; Glutamine; Humans; Metabolome; Mice; Mice, Nude; Proto-Oncogene Mas; Proto-Oncogene Proteins c-myc; Rhabdoid Tumor; Teratoma; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2019